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ABSTRACT
This article highlights the potential spiritual effects of a popular anesthetic, ketamine, and how these spiritual effects can be used
to help promote the reconciliation of spiritual and physical health. Ketamine, like the prominent psychedelic, psilocybin, has
reportedly caused feelings of spiritual revelation and “out of body experiences” that many physicians may not feel qualified to
discuss with their patients. This reluctance to address ketamine-induced spiritual experiences may affect the health outcomes of the
patient. The primary goal of this project is to bring academic validity to considerations of the spiritual health of patients. This paper
(1) investigates the extent that ketamine-induced, non-ordinary experiences can help bring awareness to the compatibility of
spiritual and physical health and (2) compares the mechanisms of ketamine and psilocybin, as well as their value to the medical
community due to the spiritual experiences that they catalyze. Thus, this research seeks to demonstrate that understanding the
spiritual value of ketamine may encourage better communication between the physician and patient and promote more holistic
healthcare approaches.

1.

BACKGROUND
To better understand how ketamine-induced
experiences are potentially “spiritual” in nature, we first
have to clarify the term “spiritual.” For the purposes of this
paper, spiritual can be defined as something that is more than
our typical waking reality—it is, at its most expansive, the
experience of becoming one with all that exists, going
beyond the boundaries of time and space. These spiritual
experiences present an interesting challenge to modern
medicine. As American medicine has become increasingly
scientific, the focus of physicians has centered on physical
and psychological care. However, there was a time that
American hospitals emphasized spiritual well-being as well.
According to Dr. Puchalski, in 1910, American medicine
changed course. The Flexner Report laid an important
foundation for American medical education’s footing in the
physical sciences. Unfortunately, this newfound grounding
undermined the spiritual elements of patient care
(Puchalski). Spirituality had a prominent role in establishing
American healthcare for centuries but was quickly masked
by the technological advances of the 20th century. With new
treatments and diagnoses, numerous lives were saved but at
the cost of once traditional medical values. American
medicine soon adopted an empirical model and the once
holistic field that accepted both secular and metaphysical
ideologies was lost. Many Western physicians, specifically
in the United States, had become intellectually advanced, but
according to Puchalski, medical personnel across the country
were becoming less and less equipped to pick up on the
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emotional (verbal and nonverbal) language of their patients.
Puchalski goes on to suggest that a part of this emotional
opacity was caused by the segregation of spirituality and
medicine (Puchalski). Yet, at the start of the 21st century,
researchers have begun to rediscover spirituality’s potential
effect on physical and mental health (Puchalski).
Modern medicine has made significant progress in
identifying and acknowledging the importance of spirituality
and what can invoke these experiences. While there is no
way to quantitatively measure a spiritual response, the
qualitative data attained from these studies are important
nonetheless. Some researchers, however, have found
significant similarities between anesthetics and psilocybin—
the active ingredient in several species of mushrooms that
catalyzes psychedelic experiences—in the physical and
subjective way the two affect the brain. Recent studies have
begun to gather empirical data on the physical effects of
psychedelics on the brain and have created theoretical
frameworks for making sense of the spiritual experiences
that are so often associated with the use of psychedelic
substances. Namely, in the article “Altered States:
Psychedelics and Anesthetics,” Eduardo E. Icaza reports,
“By comparing psychedelic and anesthetic pathways that
can alter or even ‘heighten’ consciousness, we may be able
to identify key brain areas and networks that mediate
conscious experience” (Icaza 1258). Neuroimaging
techniques have shown that psilocybin decreases cerebral
blood flow and have uncovered patterns of functional
disconnections like many anesthetics. Psilocybin
significantly decreases cerebral blood flow in the posterior

Dr. Barnard is a Professor of Religious Studies in SMU’s Department of Religious Studies.

Published by SMU Scholar, 2021

1

SMU Journal of Undergraduate Research, Vol. 6, Iss. 1 [2021], Art. 6

cingulate cortex, thalamus, and anterior cingulate cortex.
Furthermore, psilocybin reduces functional connectivity
between the anterior and posterior regions of the cortex,
similar to brain patterns found during anesthesia (Icaza
1257). For our purposes, psilocybin brain pathways compare
to those of ketamine by similar decreased connectivity in the
amygdala and anterior cingulate cortex. It is important to
note that this similarity is based on low-dose administrations
of ketamine (Icaza 1258). In anesthetic doses of ketamine,
there are significant reductions of thalamus activity like what
is found with psilocybin. The regulation of our waking
conscious and the connectivity between our emotions,
intelligence, concentration and self-awareness, as well as our
spatial and visual perception are altered similarly by
psilocybin and general anesthesia.
This biological approach to examining these
substances was supported by Michael van Elk in his article,
“Brain Mechanisms in Religion and Spirituality: An
Integrative Predictive Processing Framework”. In this
article, van Elk reported a five-point biological model for the
relationship between religious and spiritual experiences and
the brain:
1.

Temporal brain areas
Brain Structures: Hippocampus, Amygdala,
Superior Temporal Sulcus; Medial Temporal
Lobes; Fusiform Face Area
Function: Memory retrieval; Emotional coloring
of experience; Biological motion perception;
Face perception
Religious and Spiritual Beliefs: Visions;
Hallucinations; Deja-vu experiences

2.

Multisensory Integration
Brain Structures: Temporo-Parietal Junction;
Superior Parietal Lobe; Inferior Parietal Lobe
Function: Bodily self-consciousness;
Multisensory integration
Religious and Spiritual Beliefs: Mystical
experiences; self-transcendence; out-of-body
experiences; feeling of a presence

3.

Default Mode Network
Brain Structures: Posterior Cingulate Cortex;
Precuneus; Inferior Parietal Lobe; Lateral
Temporal Cortex
Function: Self-referential processing; Mindwandering
Religious and Spiritual Beliefs: Mystical
experiences; Ego dissolution; Reflective religious
beliefs

4.

Theory-of-Mind Network
Brain Structures: Medial Prefrontal Cortex;
Superior Temporal Sulcus; Temporo-Parietal
Junction
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Function: Social Cognition; Communication;
Intentionality perception
Religious and Spiritual Beliefs: Prayer; Belief in
personal God; Over-attribution of agency
5.

Error-Monitoring Mechanisms
Brain Structures: Anterior Cingulate Cortex;
Medial Prefrontal Cortex; dopaminergic system
Function: Prediction error-monitoring; Beliefmaintenance and updating
Religious and Spiritual Beliefs: Openness to
religious authority and rituals

Both psilocybin and ketamine cause decreased
amygdala connectivity. This promotes an emotional
disconnection between what is felt during the typical,
waking reality and what is felt under the influence of the
psychedelic or anesthetic. Translating this to transcendental
functions by van Elk’s biological model above, we see that
the amygdala helps regulate religious and spiritual visions
and hallucinations. In the absence of metaphysical
influences, the amygdala is a part of the limbic system—
mediating emotion and memory. More specifically, the
amygdala is associated with positive emotions and
rewarding stimuli (Salzman). When considering both the
psychedelic cognitive effects of psilocybin and the supposed
spiritual nature of ketamine, healthy individuals may
encounter positive or relatively safe visions or hallucinations
that encourage sanguine feelings in order to (1) escape
external stresses or (2) find more effective ways to deal with
those external stress factors. Decreased amygdala
connectivity induced by both drugs, then, is the result of the
individual shifting their attention from the normal conscious
world of experience and entering the subconscious in order
to explore emotions in a different way than they would
normally be able to do. This exploration of emotions,
therefore, comes in the form of hallucinations and visions
that cannot be seen if amygdala connectivity had not been
altered. Most importantly, feelings produced from the
amygdala during both psilocybin and ketamine trips are
highly likely to affect the individual after their psychedelic
explorations. Regarding patient care, this can translate to
better recovery outcomes due to the positive affirmations
and/or the emotional security that was established by the
visions during the trip.
The anterior cingulate cortex is a “meeting place”
for the limbic system, that mediates emotion, and the
prefrontal cortex, that mediates cognition. The anterior
cingulate cortex, therefore, is likely to regulate an
individual’s ability to control and manage uncomfortable
emotions (Stevens). In van Elk’s biological model for
spiritual experiences, the anterior cingulate cortex helps
regulate error-monitoring mechanisms and belief
maintenance. In terms of spiritual beliefs, the anterior
cingulate cortex promotes openness to religious authority
and rituals. As Icaza reported, both ketamine and psilocybin
influence the brain by decreasing anterior cingulate
connectivity. A healthy individual’s ability to control, avoid,
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and regulate painful emotions are mediated by the ACC. If
these connections are altered—and more specifically
decreased by the activity of psilocybin and ketamine—this
allows more abstract approaches to dealing with such
emotions to be utilized. Therefore, under spiritual influences
such as those that are at times provided by ketamine,
authoritative religious figures or beliefs can be a determining
factor in how the individual reacts to stresses after their
psychedelic experience.
These similarities in the biological mechanisms of
the two drugs are supported in the post-psychedelic
recollections of several healthy individuals. Although van
Elk established a biological model for making sense of
general spiritual experiences, Dr. Eli Kolp provided a
different approach to studying the effects of spiritual
experiences on the brain. Dr. Kolp, with the assistance of
other physicians and researchers, studied the conscious
effects of ketamine in a psychedelic psychotherapy study,
focusing on the phenomenology and clinical applications of
the profound mystical effects of the drug. Psychedelic
psychotherapy typically occurs while the patient is under the
influence of a psychedelic. From this study, Dr. Kolp
reported that when using:
“…one-sixth to one-tenth of the dose used for
general anesthesia, ketamine can create psychedelic
experiences with disconnection from surroundings,
perception of floating becoming disembodied as a mind or
soul, and even dying and going to a different world…loss of
reality contact appears more pronounced than with other
psychedelics” (Kolp, et al).
These sub-anesthetic does of ketamine can
produce the shifts in conscious thought that encourage
spiritual experiences. Dr. Andrew Bowdle, author of
“Psychedelic Effects of Ketamine in Healthy Volunteers:
Relationship to Steady-state Plasma Concentrations,” stated
“ketamine produced dose-related psychedelic effects”—
supporting that different doses of ketamine can produce
significantly psychedelic, and thus, spiritual experiences
(82). Dr. Bowdle also reported, “Awareness of these effects
may help clinicians using subanesthetic doses of ketamine
improve their management of patients, particularly with
regard to effective communication with patients” (86).
Specifically, the effects that Dr. Bowdle refers to are
explicitly stated in Dr. Kolp’s article, “Ketamine
Psychedelic Psychotherapy: Focus on Its Pharmacology,
Phenomenology, and Clinical Applications.” According to
Dr. Kolp, the ketamine-induced, non-ordinary experiences
may include:
Emotionally intense visions (deceased relatives,
angels, spirits)
Encounters with archetypal beings (Christ,
Buddha, Krishna)
Feelings of cosmic unity with the Universe and
God
Sense of sacredness
Feelings of interconnectedness with all people and
nature
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The above components of ketamine-induced
experiences directly align with ketamine’s involvement in
altering the amygdala (emotionally intense visions,
encounters with archetypal beings) and the anterior cingulate
cortex (feelings of cosmic unity with the Universe and God)
as reported by Dr. Icaza.
At high doses, ketamine experiences can induce an
ego-dissolving, transcendental experience for the patient,
including:
Feelings of interconnectedness with all people (or
sense of experiencing collective consciousness)
Feelings of becoming God, frequently experiences
as an ocean of brilliant white light
Profound sense of sacredness of the experience
These ego-dissolving, transcendental experiences
can generate some resolution of the patient’s addictive
illnesses, psychological problems, and personality disorders,
including spontaneous healing from chronic psychosomatic
illnesses (Kolp, et al). It is important to note that
transcendental experiences can occur with subanesthetic and
high doses of ketamine.

2.

METHODOLOGY
This project is constructed as a literature review.
Specifically, it analyzes previous studies on the spiritual
aspect of ketamine and how these ketamine experiences can
help establish a more holistic healthcare system. This
project also compares the spiritual experiences between
ketamine and psilocybin, a classic psychedelic that has also
been reported to provide "spiritual" effects. The mystical
experiences induced by psilocybin have been found to have
enormous value, specifically in psychotherapy. This
comparison will be used to question whether ketamineinduced experiences should be deemed valuable as well.
Finally, the comparison of ketamine to psilocybin as well
as testimonies of ketamine users will be used to argue the
necessity of reconciling spiritual and physical health.
Most sources were collected from the PubMed
National Library of Medicine database. Search terms
included “spirituality and medicine,” “spirituality and
health,” “spirituality and ketamine,” “ketamine and
psychedelics,” and “psychedelics and medicine.” The peerreviewed journal of the American Society of
Anesthesiologists was employed as well. Search terms from
this journal included “anesthetics and spirituality,”
“anesthetics and mystical experiences,” and “anesthetics
and psychedelics.”
3.

RESULTS

The spiritual testimonies of recreational ketamine
users were compelling. One user reported:
“I rose into the Light and found myself having an
unspoken interchange with the Light, which I believed to be
God, about matters which seemed to be of central
importance to my Life and who I was. I didn’t believe in
God, which made the [ketamine] experience even more
startling. That experience seriously shook the basis of my
belief” (Jansen 99).
Another user revealed,
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“[Ketamine] was very upsetting, and it did shake
my atheism, very much so. I’m just really pleased that I
found it when I did because I think it was a Godsend actually.
I regard [ketamine] as a sort of spiritual enhancer” (Jansen
101-105).
Those who have had experience with ketamine
insist that the events they encounter are real—they are not
hallucinations or dreams. These first-hand accounts do
support the hypothesis that ketamine experiences are
spiritually valuable. To offer a description of how influential
ketamine-induced experiences are to patient care, and thus,
the reconciliation of spiritual and physical health, I employ
a room-door metaphor illustrating the importance of
recognizing this transcendental phenomenon to the physical
body:
If we consider the physical body to be a door
leading to a room, the room will symbolize the
subconscious. Within this room holds our ability, or
capacity, to have, maintain, and regulate transcendental
experiences. When we think of a room, we presume the door
is a part of the room. The two are not dissociated, or separate
from one another, but are instead, considered to be
distinguishable. An individual is only ever to acknowledge
the subconscious when he or she separates themselves from
the conscious, waking reality. Ketamine is an avenue to
promote this separation.
The physical mechanisms that are affected by
ketamine in anesthetic practices directly affect the state of
the conscious mind by increasing subconscious activity.
With heightened subconscious awareness, the capacity to
welcome and understand spiritual concepts is increased, and
the result of doing so can affect how the patient chooses to
physically manage their recovery process.
There are other side effects of ketamine. “K pains”
are severe stomach pains that can hospitalize the user. Karl
Jansen reported in his book, Ketamine: Dreams and
Realities, that these “K pains” are a form of irritable bowel
syndrome (Jansen 271). These stomach pains may be the
physiological result of emotional stress that occurs when the
user is undergoing a powerful ketamine-induced psychedelic
experience. Other physiological responses due to ketamineinduced, non-ordinary experiences can include chest pain
and rapid heartbeat, increased blood pressure, and increased
susceptibility to infection (Schneiderman). Physicians,
specifically anesthesiologists, should consider these
experiences important to their patients’ health in that
neurotic experiences often have physiological effects.
However, as Dr. Bowdle notes, “anesthesiologists tend to
associate the psychedelic effects of ketamine with
emergence from anesthesia, after use of ketamine as an
induction agent, which is often referred to as ‘emergence
reactions’” (Bowdle, et al). Roughly 55% of those
administered ketamine will experience an emergence
reaction that mimics schizophrenia and increases that
patient’s risk of injury (Aroke, et al). The misattribution of
these spiritual experiences as emergence phenomena
accredited to mental illness, and the physician’s
subconscious treatment of post-ketamine reactions as such,
can arguably create unintended roadblocks in the patient’s
treatment.
Although harmful side effects can occur,
ketamine-induced, non-ordinary experiences can encourage
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stable recovery from illness and injury by promoting
patients’ psychospiritual growth (Ketamine-Enhanced
Psychotherapy). Spirituality can be utilized as a method to
relieve physical symptoms and to confront and endure the
emotional distress that can accompany physical illness.
Patient recovery is largely dependent upon the individual’s
ability to relate to their self, to others, and to the physical
world. For example, transcendental experiences can stabilize
emotional responses to external stressors, such as physical
injury. Without healthy emotional responses, the body
cannot respond properly because that unhealthy emotional
response has become an acute, or in severe cases, chronic,
stressor. For the purposes of this paper, these unhealthy
emotional responses can occur because of distressing or offputting visions or hallucinations while undergoing a
ketamine trip. These can induce a vascular response,
specifically, increasing blood pressure through constriction
(Schneiderman). Minimizing the effect spirituality has on
physical recovery can risk the progress of a patient’s return
to health.
Dr. Matthew Johnson conducted a study analyzing
psilocybin and its mystical effects during several therapeutic
trials related to the psychological distress and depression
catalyzed by cancer. His analysis suggested that the positive
therapeutic outcomes are mediated by the drug’s ability to
produce spiritual experiences (Johnson 95). These nonordinary, mystical experiences produced from psilocybin
include changes in perceptual, cognitive, and affective
thinking (Griffiths). Psilocybin is a part of a serotoninmediated class of hallucinogens, along with lysergic acid
diethylamide (LSD) and N,N-dimethyltryptamine (DMT).
Prominent
themes
of
serotonergic-hallucinogenic
experiences include (Strassman):
Timelessness
Ineffability
Contact and unification with an authoritative
presence
Experience of a white light
Certainty that consciousness continues after
physical death
Firsthand knowledge of the ‘facts’ of creation,
existence, and consciousness
Prominent themes of ketamine-induced, nonordinary experiences include (Kolp, et al):
Feelings of becoming God
Sense of sacredness
Feelings of cosmic unity with the Universe and
God
Encounters with archetypal beings
Emotionally intense visions
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Similarities between the synthetic drug, ketamine,
and the plant-produced psilocybin include euphoria,
peacefulness, spiritual awakening, and quickly changing
emotions. More apparent similarities are depersonalization,
and distorted thinking and/or rationales. These similarities
are characterized by their abruptness and by their ability to
be sustained over significant periods of time. This research
also indicates that ketamine-induced experiences do not
produce lasting effects as consistently as psilocybin-induced
experiences. In a dose-dependent psilocybin study analyzing
the long-term psychological effects of hallucinogenics,
researchers found that high-dose psilocybin (20-30
mg/70Kg) produced acute and persisting effects after six
months. Participants in the study experienced lasting
feelings of interpersonal closeness, death transcendence,
daily spiritual experiences, and religious faith and coping
(Griffiths, et al). Typical therapeutic psilocybin dosage is 25
– 30 mg/70kg. The similarity in therapeutic and nontherapeutic psilocybin dosage, and lack thereof for ketamine,
can explain why ketamine-induced experiences have not
been understood to be as psychologically valuable as the
experiences catalyzed by psilocybin. The lack of research
regarding dose-related ketamine-induced experiences in
various sets and settings, in addition to positive therapeutic
results attributed to psilocybin due to its capacity to produce
these mystical experiences, helps establish psilocybin’s
effectiveness but does not signify ketamine’s relevance in a
bio-spiritual context. With more research, it may be possible
for ketamine-induced experiences to also be medically
valuable.
Regarding the need for spiritual concern in
medicine, Dr. John Tarpley examined public opinion polls
and surveys that showed that the majority of patients want
their physicians to inquire about their spiritual concerns and
health. However, studies also indicated that many physicians
were uncomfortable discussing spiritual issues (Tarpley
644). Additionally, Doctor Elaine Yuen proposed that
spiritual and religious practices have benefited those with
physical conditions such as kidney disease, cancer,
cardiovascular disease, HIV, and diabetes mellitus. Religion
and spirituality also support psychological coping
mechanisms, addressing the physical discomfort that
accompanies illness and injury (77). Effective
communication practices regarding patients’ spiritual health
and experiences do require physicians to be more present as
a person, rather than as a physician. It is important to the
patient’s health and to the overall patient-physician
relationship for the physician to be more attentive to all
possible causes of patient suffering, and in some ways, to
separate themselves from their profession in order to gain
better insight about the patient. This willingness of a
physician to be a fellow human welcomes patient
vulnerability and allows the physician to familiarize
themselves with the patient’s personal experiences, which, if
need be, can be appropriately incorporated into their
treatment plan.

4.

DISCUSSION
This paper aims to provide a context to examine
the extent that ketamine-induced, non-ordinary experiences
can help bring awareness of the compatibility of spiritual and
physical health. To study this principal question,
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comparisons were made between the anesthetic ketamine
and a serotonergic hallucinogen, psilocybin. In addition, the
validity of these ketamine-induced spiritual experiences was
examined. To fully understand the capacity that ketamine
possesses to help reconcile spiritual and physical health, it is
crucial that spiritual health, as distinct from spirituality, be
better defined in any future research.
Physical, mental, and social perspectives all make
up the human experience. However, the aspects of human
existence that cannot be rationalized within these contexts
make up individual spiritual health. Spiritual health is an
actualization of the differing capacities of human existence.
It is how well the individual functions in a shared, waking
reality with others based on their individual knowledge of
what they perceive to exceed this shared reality. Spiritual
health, at its essence then, is the balance between the
physical and emotional aspects of existence. It is how we
tangibly and cognitively perceive ourselves in relation to
other existing possibilities as we know them. Spiritual health
does not require constant internalization of positive feelings
or belief in a higher power. Instead, it requires individual
discernment of all possible forms of existence. The idea of
being spiritually unhealthy, therefore, is the result of
dissonance between the individual’s understanding of
transcendent ideas and their everyday, waking reality.
Ketamine can be utilized to promote the
reconciliation of spiritual and physical health by (1)
encouraging the patient to challenge traditional social
constructs and belief patterns at the cost of discovering
personal revelations; (2) inducing psychological stressors
that can have physical effects; and (3) allowing for more
open patient-physician conversations. As Kolp described,
“…the ego-dissolving transcendental experiences [of
ketamine] sometimes generate some resolution of the
patient’s addictive illnesses, psychological problems, and
personality disorders, including of spontaneous healing from
chronic psychosomatic illnesses” (Kolp, et al). It is clear that
discussing personal experiences such as these can at times
create discomfort for the physician and/or patient; however,
the vulnerability experienced during these conversations
could have substantial positive outcomes on the patient’s
ability to manage physical injury.
These types of
conversations would require an intimate relationship
between the patient and physician in order to discuss the
aftermath of ketamine-induced, non-ordinary experiences,
and the willingness of the physician to consider those
experiences in their treatment plans.
Ketamine is of special interest in integrating
spirituality and modern medicine because of its role in pain
management. Pain perception is composed not only of
physical mechanisms and response, but emotional factors as
well. Spiritual stressors can catalyze pain responses, and
ketamine-induced, non-ordinary experiences at anesthetic
doses can alter patients’ pain perception. Subsequently, pain
management options should reflect these non-physiological
factors. To efficiently assign pain treatment options,
however, physicians must possess a comprehensive
understanding of these ketamine-induced experiences.
Patients’ capacity to tolerate and accept disease
and injury requires multiple levels of experience and thought
(Dedeli). The psychedelic effects associated with ketamine
encourages a detachment from these thoughts processes—
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bringing forth a sense of intense and often overwhelming
spiritual vulnerability for the patient. Therefore, an
individual’s perception of pain may be significantly altered
by ketamine because he or she is not experiencing typical,
waking-reality thought processes but is instead experiencing
unfamiliar, subconscious levels of thought. That is to say,
these spiritual experiences are ordinarily invisible to us and
are inaccessible using our normal states of consciousness
(Strassman 54). Consequently, these spiritual-in-nature,
ketamine variables may alter the patients’ response to
various pain experiences, thus affecting their recovery
options (Dedeli).

5.

CONCLUSION

This paper does not encourage the recreational use
of ketamine, nor does it propose ketamine should be utilized
as a therapeutic substance. However, this paper aims to raise
questions regarding training improvements for medical
students. It is important to objectively measure the level of
“spiritual training” necessary to become knowledgeable
with spiritual health, and therefore how to improve the
patient-physician relationship. Going further, future studies
would need to objectively measure the direct relationship
specifically between ketamine-induced experiences and the
physical outcomes of treatment to provide a more stable
argument for the compatibility of spiritual and physical
health.
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